Compare · AKUS vs NPT
AKUS vs NPT
Side-by-side comparison of Akouos Inc. (AKUS) and Texxon Holding Limited (NPT): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AKUS and NPT operate in Specialty Chemicals (Consumer Discretionary), so they compete in similar markets.
- NPT carries a market cap of $38.8M.
- NPT has hit the wire 2 times in the past 4 weeks while AKUS has been quiet.
- AKUS has more recent analyst coverage (1 ratings vs 0 for NPT).
- Company
- Akouos Inc.
- Texxon Holding Limited
- Price
- -
- -
- Market cap
- -
- $38.8M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Specialty Chemicals
- Specialty Chemicals
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2020
- 2025
- News (4w)
- 0
- 2
- Recent ratings
- 1
- 0
Akouos Inc.
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. The company is also developing AK-CLRN1 for the auditory manifestations of Usher syndrome 3A, or USH3A; and AK-antiVEGF for vestibular schwannoma. In addition, its precision genetic medicine platform addresses hearing loss related to genes needed for supporting cell function. Akouos, Inc. was incorporated in 2016 and is based in Boston, Massachusetts.
Latest AKUS
- SEC Form SC 13G/A filed by Akouos Inc. (Amendment)
- SEC Form SC 13G/A filed by Akouos Inc. (Amendment)
- SEC Form SC 13G/A filed by Akouos Inc. (Amendment)
- SEC Form SC 13G/A filed by Akouos Inc. (Amendment)
- SEC Form 15-12G filed by Akouos Inc.
- SEC Form EFFECT filed by Akouos Inc.
- SEC Form 4 filed by Walker Paul Edward (tax withholding)
- SEC Form 4 filed by Sonsini Peter W. (tax withholding)
- SEC Form 4 filed by Sandell Scott D to satisfy withholding tax
- SEC Form 4 filed by Mathers Edward T (tax withholding)
Latest NPT
- Texxon Holding Limited Announces Financial Results for Fiscal Year 2026
- SEC Form NT 20-F filed by Texxon Holding Limited
- Texxon Holding Limited Announces Commencement of Operations at Henan Polystyrene Production Facility, A Milestone in Manufacturing Expansion Strategy
- SEC Form 6-K filed by Texxon Holding Limited
- Texxon Holding Limited Announces Unaudited Financial Results for the First Half of Fiscal Year 2026
- SEC Form 6-K filed by Texxon Holding Limited
- SEC Form 6-K filed by Texxon Holding Limited
- Texxon Holding Limited Announces Annual General Meeting
- SEC Form 3 filed by new insider Xu Hui
- SEC Form 3 filed by new insider Huang Jian (Hanke)